Bain Capital

Bain Capital, founded in 1984 in Boston, Massachusetts, is a leading multi-asset alternative investment firm with over $95 billion in assets under management. The firm operates business units focused on private equity, public equity, credit, and venture capital across various sectors and industries. Bain Capital has a global team with 19 offices worldwide and more than 950 employees. Through the Bain Capital Community Partnership, the firm supports charitable and nonprofit organizations globally, including the Bain Capital Children’s Charity. Bain Capital Double Impact specializes in impact investing, aiming to build companies that deliver financial returns alongside social and environmental benefits. Bain Capital Life Sciences Fund focuses on buyouts, growth capital, and private equity investments in the life sciences sector, while Bain Capital Specialty Finance, Inc. operates as a business development company specializing in direct loans to middle-market companies.
Room 3658-60, 36/F Two IFC 8 Century Boulevard Shanghai, 200120, China / 47/F Cheung Kong Center, 2 Quee' Road Central, Hong Kong

Bear Albright

Managing Director, Investor Relations

Ernesto Anguilla

Managing Director & Head of Communications & Public Affairs Corporate

Brad Balter

vice_president

Luca Bassi

Partner, Private Equity & Managing Director

Kyle Betty

Managing Director and Global Head of Bain Capital Credit Investor Relations and Business Development

Riddhi Bhalla

Director; Investor Relations, Credit

Colin Campbell

Managing Director & Partnership Strategies

Jonah Cashdan

vice_president

Amit Chandra

Partner, Private Equity

Cecilia Chao

Managing Director

Mike Choi

Principal

John P. Connaughton

Co-Managing Partner

Todd M. Cook

Managing Director

Will Cozean

Principal, Life Sciences

Daniel Cummings

Managing Director & Head of Bain Capital Real Estate

Jacob Donnelly

Partner

Jeff Doran

Director, Investor Relations, Credit

Nicholas Downing

Principal

Eric Erb

Managing Director

Clark Feng

Managing Director

Nick Gattas

vice_president

Thatcher Gearhart

Director

Andrew Hack

Managing Director

David Hamilton

SVP of Information Technology

Kenneth J. Hanau

Managing Director

Alena Harrison

vice_president

Ray Hass

Managing Director

James Henry Hildebrandt

Managing Director, Investor Relations

Jim Hildebrandt

Managing Director

Anne Holloway

vice_president

Shintaro Hori

Senior Advisor

Viva Hyatt

Managing Director

Abhiroop Jayanthi

Principal

Andrew Kateiva

Managing Director

Scott Kirk

Partner

Ryuto Kobayashi

Managing Director

Adam Koppel Ph.D

Partner, Life Sciences

Jonathan Lavine

Co-Managing Partner

Charles Lawson

Principal

Ritika Mahal

vice_president

Rishi Mandawat

Managing Director

Marc Mander

Director

Vibhu Manya

Operating Partner, Private Equity

Robin Marshall

Partner and Co-Head of the European Private Equity

Michael McArdle

Managing Director, Investor Relations

Michael McCarron

MD

Michael Murphy

Partner, Private Equity

Nicholas Onie

Principal of Asia Pacific Private Equity Team

Sam Payne

vice_president

Marlene Wojcik Reynolds

CFO, Brookside

Peter Riehl

Managing Director

Steve Rizoli

vice_president

Serge Walid Sarkis

MD

Matt Sears

VP

Greg Shell

MD

Hans Sherman

Partner, Tech Opportunities

Pawaan Singh

Associate

Pavninder Singh

Partner, Private Equity

Peter Spring

Partner, Double Impact

Mitchell Stack

Managing Director; Investor Relations, Credit

Masa Suekane

Managing Director

Yuji Sugimoto

Partner

Patrick Sullivan

Partner, Investor Relations

Dorothy C. Sumption

Director, Investor Relations

Ricky Lijing Sun

Managing Director

Richard Waitumbi

vice_president

Alex Wang

Director, Investor Relations

Harris Weber

vice_president

Jurjen Van der Wiel

Managing Director

Steven Wolin

SVP

Ray Xi

VP

Frank Yao

Managing Partner, Private Equity

Amir Zamani

Principal

Jayne Zecha

Partner

Jia Zhu

Partner

201 past transactions

Baron App, Inc.

Private Placement in 2019
Baron App, Inc., doing business as Cameo, operates a marketplace that enables fans to book a personalized video shout-out from their favorite talent. It offers CAMEO, a marketplace that is used to create personalized and authentic fan experiences though its website and app. Baron App, Inc. was founded in 2017 and is based in Chicago, Illinois.

Sustainable Restaurant Group

Private Equity Round in 2018
Sustainable Restaurant Group is a collection of brands that are defining the future of hospitality through a deep commitment to environmental and social change. We make mindful business decisions that connect environmental impact, the prosperity of our team members and purveyors, as well as the enrichment of the communities we live in. We seek opportunities to create new concepts that inspire change by providing an innovative experience that meets the mind and enlivens the spirit.

Skylark

Acquisition in 2012
Skylark is one of the largest casual dining restaurant chains, with approximately 3,200 company operated restaurants across multiple brands and formats specializing in Western, Japanese, Italian and Chinese cuisines under the Gusto, Bamiyan, Yumean, Jonathan's, Steak Gusto, Grazie Garden's, Ohashi Café Gusto, Aiya, S Gusto, Totoyamichi, Shabuyo, Karayoshi, Chawan, Tonkara-tei, La Ohana, and Murashi no Mori Coffee brand names.

By Chloe

Venture Round in 2018
by CHLOE. aims to share delicious, wholesome, plant-based food that fuels and energizes without compromising flavor, taste or satisfaction. Their chef-driven vegan menu features locally-sourced ingredients in their most natural form to create inspired dishes, made 100% by us daily. We are passionate about feeding their customers hearty, nourishing meals made from whole ingredients that can have a positive impact on their overall mind, body and health.

RentoMojo

Series C in 2019
RentoMojo is an online furniture rental platform that was incorporated in November 2014.It currently operates in Bangalore, Pune, Mumbai, Hyderabad, Chennai, Delhi, Gurgaon and Noida. RentoMojo was founded by Geetansh Bamania, an ex-IITM, in November 2014 in India. Like many other young working professionals, he was living in rented apartments, working long hours and found it inconvenient to equip the house with furniture when he moved. RentoMojo was developed to provide an alternative to buying and selling furniture in rental properties.

Invoke Solutions

Venture Round in 2011
Invoke Solutions offers real-time online research services that offer fast, usable insights for their clients. Invoke Solutions products are used by companies including Microsoft, Washington Mutual, Conagra, Dell, erBay, Verizon, and Nestle to conduct better, faster, brand, communications, and product research in the US and globally. Their Engage online and mobile applications enable clients and partners to blend qualitative and quantitative real-time research. (Source: [Invoke Solutions](http://www.invoke.com))

Netfish Technologies

Venture Round in 2000
Netfish Technologies offers internet-enabled companies with XML-based B2B process collaboration solutions. It offers business process automation solutions for procurement, order fulfillment, billing, payment, and more. Netfish Technologies offers tools to integrate enterprise applications and data to enable the exchange of business information. Netfish Technologies was founded in 1997 and is based in Santa Clara, California.

Arcutis Biotherapeutics

Series B in 2018
Arcutis Biotherapeutics is a privately held clinical-stage biopharmaceutical company focused on developing and commercializing treatments for unmet needs in immune-mediated dermatological diseases and conditions, or immuno-dermatology.

Asatsu DK

Acquisition in 2017
Asatsu-DK Inc., is a Japanese advertising agency. It offers online media planning and buying, interactive campaign planning and operation, campaign planning and operation, production and research, consulting, and interactive/digital media business development services. The company is headquartered in the Toranomon Hills building complex in Minato, Tokyo.

HookMedia

Series B in 2000
HookMedia offers a range of Internet marketing services including the planning, placement and optimization of interactive media, proprietary reporting, analysis and database services.

Asia Pacific Medical Group

Acquisition in 2016
Asia Pacific Medical Group Limited operates hospitals and healthcare clinics that provide medical services to patients in China, South East Asia, and internationally. It provides gamma-knife treatment procedures; neurology and neurosurgery services; non-invasive cosmetic dermatology and plastic surgery services; and intensity modulated radiation therapy services for treating tumors of various locations, including brain tumors, head and neck tumors, lung cancer, esophagus cancer, breast cancer, hepatic cancer, pancreas cancer, prostate cancer, etc. The company was founded in 1992 and is based in Causeway Bay, Hong Kong.

Daymon Worldwide

Acquisition in 2017
Daymon WorldwideWith a foundation of more than 40 years of experience, today Daymon is the global leader in consumables retailing.As a global company operating on six continents, we bring an enterprise-wide window to the world and real-time experience that is surpassed by none. Our ability to translate this experience into unique and customized strategies is the engine that drives increased sales and share, in collaboration with our retail customers and supplier partners. Our network of more than 39,000 talented associates deliver targeted solutions grounded in actionable insights.The companies of Daymon Worldwide provide end-to-end retail services focused on: Private Brand Development Strategy & Branding Sourcing & Logistics Retail Services Consumer Experience Marketing

RentoMojo

Venture Round in 2021
RentoMojo is an online furniture rental platform that was incorporated in November 2014.It currently operates in Bangalore, Pune, Mumbai, Hyderabad, Chennai, Delhi, Gurgaon and Noida. RentoMojo was founded by Geetansh Bamania, an ex-IITM, in November 2014 in India. Like many other young working professionals, he was living in rented apartments, working long hours and found it inconvenient to equip the house with furniture when he moved. RentoMojo was developed to provide an alternative to buying and selling furniture in rental properties.

Accelecare

Venture Round in 2007
Based near Seattle, Washington, Accelecare Wound Centers® is a comprehensive wound care and disease management company. Accelecare provides full service wound management solutions to hospitals and related health care organizations across the United States. Accelecare offers state of the art Advanced Wound Centers staffed with trained physicians, nurses, and specialized technicians providing efficacious and cost effective wound treatments ensuring positive outcomes. The company’s mission is centered around partnering with hospitals in order to provide caring services for patients with the highest level of clinical excellence.

Evident.io

Series C in 2017
As of March 26, 2018, Evident.io, Inc. was acquired by Palo Alto Networks, Inc. Evident.io, Inc. develops and offers a software platform for enterprise security management. The company offers cloud security services, including resource visibility, vulnerability assessment, and notifications and alerting; risk and compliance services; and Amazon Web services. Evident.io, Inc. was incorporated in 2013 and is based in Pleasanton, California.

SevOne

Series B in 2013
Provides infrastructure performance monitoring solutions for customers worldwide

VMLogix

Series A in 2006
VMLogix, Inc. provides virtual infrastructure management technology to streamline the software development lifecycle for software companies and IT organizations. It offers VMLogix LabManager that enables developers, testers, and IT operations staff to consolidate lab infrastructure, and automate build and test processes. VMLogix, Inc. was formerly known as SQA Technologies Pvt., Ltd. The company was founded in 2004 and is headquartered in Palo Alto, California with additional offices in Bangalore, India; and Toronto, Canada.

Diversey

Acquisition in 2017
Diversey, Inc. is a leading global provider of cleaning and hygiene solutions to the institutional marketplace, serving customers in the lodging, food service, retail, health care, food and beverage sectors, as well as building service contractors worldwide. Diversey is proud of its capabilities to deliver to its customers and their employees superior and sustainable cleaning, sanitization and hygiene solutions. The company has a platform to showcase the passion of its people for providing a cleaner, healthier future for generations to come.

Consolis SAS

Acquisition in 2017
Consolis manufactures concrete products for residential and non-residential construction and also for infrastructure projects such as the construction of bridges or sewers.

Harry's

Series E in 2021
Harry is a developer of an online platform used to sell shaving equipment and accessories for men. It designs and manufactures its own line of razors and replacement blades, as well as other shaving consumables, and offers its products a-la-carte via its online store or through a subscription model that enables consumers to meet their grooming essentials need online. The company was founded in 2013 and is headquartered in New York.

Socar

Series B in 2015
Socar is a Korean eco-friendly car sharing community that allows travelers to share cars with others who are traveling the same route. Socar has raised an $18 million round of funding in 2015 which was one of the highest funding deals for a South Korean startup to date. Most notably, it was led by a US investor: Bain Capital, a private investment firm with $80 billion in assets under management. Socar was founded in March 2012, and it has a website and smartphone apps that let users book cars for their own use. Service has over 1,700,000 registered users, 50,000 of whom use the service each month. Around 80,000 transactions per month — that’s more than one car booking each 30 seconds.

GreenLight Fund

Private Equity Round in 2021
GreenLight Fund

Ricerca Biosciences - CRO and CDMO

Venture Round in 2010
CRO is supporting the development and manufacturer.

Viewpoint

Secondary Market in 2014
Viewpoint is the global provider of integrated software solutions for the construction industry. We are trusted by nearly 8,000 customers to connect their office, team and field operations, improving project profitability, enhancing productivity, and effectively collaborating across the broad construction ecosystem. Our innovations transform construction by aligning financial and HR systems, project management tools, and mobile field solutions to minimize risk and increase efficiency.

Hand in Hand Soap

Funding Round in 2021
Founded in 2011 by husband-and-wife team Bill Glaab and Courtney Apple, Hand in Hand is a mission-driven personal care brand with a robust Give Back program that aims to save lives through access to good hygiene and clean water. For every product purchased, Hand in Hand donates a bar of soap and clean water to a child in need. Over the past 10 years, the Company has donated over 13 million bars of soap and provided thousands with access to clean water. Hand in Hand also takes a leading position on sustainability that includes a unique, industry-leading, and portfolio-wide commitment to making only palm oil free products, and to educating consumers on the devastating environmental impacts and human rights abuses in the palm oil industry.

21 Medical Office Buildings Portfolio

Merger/Acquisition in 2019
21 Medical Office Buildings Portfolio comprises commercial real estate properties. The asset is located in the United States.

Vention

Private Placement in 2019
Vention Inc. operates a cloud platform to design and order custom machines. The company provides 3D Machine Builder, a cloud based assembly software; MachineMotion that allows automation specialists and first timers to automate their design; and T-slot aluminum extrusion systems for precision and rigidity. Its products and services allow mechanical designers to design, order, and share their custom machines directly from web browsers. The company was founded in 2016 and is headquartered in Montreal, Canada.

iWon

Private Equity Round in 2000
iWon is a CBS-backed destination portal that combines search, content, and functionality.

Dealtime.com

Series C in 2000
DealTime.com is a service of eBay Commerce Network, a leading provider of comparison shopping services. DealTime is an easy-to-use comparison shopping tool that makes it simple to find the right product at the right price. Dealtime focuses on finding great deals on sale to be sure to always find the best deal from thousands of online stores. They work with top brands and stores such as eBay, Macy's, Target, and Canon. As ecommerce evolves, sellers and buyers are increasingly sophisticated and adventurous, demanding more choice. Consumers want the widest range of products and stores, along with the information and data necessary to navigate those choices efficiently. Merchants demand exposure to the ever-expanding, global population of shoppers. DealTime's mission is to help consumers anywhere use the power of information to find, compare and buy anything! DealTime.com is a service of eBay Commerce Network, part of eBay Inc., a company incorporated in the United States with offices at 2145 Hamilton Avenue, San Jose, CA 95125 USA

X4 Pharmaceuticals

Post in 2022
X4 Pharmaceuticals a clinical-stage oncology company developing best-in-class oral small molecule CXCR4 antagonists for the treatment. The company is developing two unique programs such as drug candidate, X4P-001, has clinical experience in over 70 subjects, and is advancing into Phase 1/2 trials in refractory clear cell renal cell carcinoma (ccRCC) and refractory epithelial ovarian cancer (EOC), the second program, X4P-002, is a unique series of late lead molecules that penetrate the blood-brain barrier. They will pursue early clinical development in glioblastoma multiforme (GBM), a rare form of lethal brain cancer, for the X4P-002 program. X4 Pharmaceuticals was founded in 2014 and is based in Cambridge, Massachusetts, United States.

LaLa Media

Venture Round in 2006
Lala was a revolutionary cloud-based hub for online music discovery and purchase, enabling consumers to more effectively manage their digital music, find and purchase new titles that fit their taste, and access music recommendations through a variety of digital channels. Lala was acquired by Apple in 2009.
Himadri Speciality Chemical Ltd. is an established brand with a strong proven track record in the speciality chemicals business. It is listed in BSE and NSE. The Company specializes in developing innovative products with emphasis on R&D and focus on maximum utilization of resources. Globally, HSCL is amongst the few completely integrated speciality carbon companies leveraging on its deep knowledge of one of the most versatile substances - Carbon. Over the years, with its core products and value-added by-products, the Company has established itself as one of the world’s most extensive value chains in the Carbon segment. The Company is India’s leading and ONLY vertically-integrated specialty Carbon Corporation, being the largest producer of coal tar pitch in India with ~70% market share catering to requirements of Indian graphite and Aluminium industries.

Oedo-Onsen Holdings

Acquisition in 2015
Best known for its spa on the man-made island of Odaiba in Tokyo

Broadstep Behavioral Health, Inc.

Private Placement in 2020
Broadstep Behavioral Health, Inc., through its subsidiaries, provides healthcare services. The company provides residential, educational, day treatment/vocational, community, educational, therapeutic foster care, transportation, and training/consultation services. It serves children, adults, and families living with developmental, behavioral, mental health, and social complexities. Broadstep Behavioral Health, Inc. was formerly known as Phoenix Care Systems, Inc. and changed its name to Broadstep Behavioral Health, Inc. in May 2020. The company was founded in 1972 and is based in Milwaukee, Wisconsin. It has locations in Illinois, New Jersey, South Carolina, Indiana, and Wisconsin.

Cortera

Venture Round in 1999
Cortera is a provider of comprehensive business-to-business payment and purchase behavior data and insights on public and private companies. The company tracks $1.6 trillion in business-to-business purchases across 45 spend categories to deliver insights on 20 million U.S. business locations. Cortera's solutions enable companies of all sizes to better understand their customers, suppliers and business partners by gaining visibility into what they purchase, how they pay and how their purchase and payment behavior changes over time. Thousands of companies across diverse industries use Cortera solutions to increase revenue, improve sales and marketing effectiveness, and reduce risk. Cortera is privately held with offices in Boca Raton, Florida; Boston and Quincy, Massachusetts and Bangalore, India.

BuyWithMe

Series C in 2011
BuyWithMe is the premier group buying website where leading local merchants offer exclusive limited time offers to members of the BuyWithMe community. Through the power of its numbers, BuyWithMe negotiates handpicked group discounts for its customers to access at spas, restaurants, health clubs, bars and other local activities in their city. BuyWithMe currently publishes daily deals in 12 major DMAs, including Austin, Boston, Chicago, Dallas, Houston, Los Angeles, Philadelphia, Phoenix, New York, and San Diego. BuyWithMe is headquartered in New York City, and maintains an office in Boston where it was founded. BuyWithMe was founded by serial entrepreneur and value investor Andrew Moss.

Imperative Care

Series D in 2021
Imperative Care, Inc. develops solutions to help clinicians improve the speed of acute stroke treatment. It offers Large Distal Platform, a large diameter catheter to track farther and get closer to the treatment site for ischemic and hemorrhagic stroke procedures. The company also provides ZOOM Aspiration System, a complete stroke solution to work with the Large Distal Platform and trackable reperfusion catheters for clot removal in various sizes to treat occlusions from ICA to M2. The company was incorporated in 2015 and is based in Campbell, California.

Burlington Stores

Acquisition in 2006
Burlington Coat Factory is a leading off-price apparel and home product retailer. They operate 567 stores in 45 states and Puerto Rico, where you’ll find a large assortment of current, high-quality, designer and name-brand merchandise at up to 65% off other retailers' prices. Choose from a large selection of coats, clothing, and shoes for the entire family. And don’t forget their great assortment of linens and home décor. In Baby Depot, you’ll find everything you need for baby, from baby bottles to cribs.

Rapid Micro Biosystems

Venture Round in 2020
Rapid Micro Biosystems provides products for the detection of microbial contamination in the manufacture of pharmaceutical, biotechnology, and personal care products. It offers the Growth Direct System, a non-destructive method for microbial enumeration. The company was formerly known as Genomic Profiling Systems and changed its name to Rapid Micro Biosystems in 2007. Rapid Micro Biosystems was founded in 2006 and is based in Bedford, Massachusetts.

Reonomy

Series D in 2019
Reonomy leverages big data, partnerships, and machine learning to connect the fragmented world of commercial real estate. Reonomy products empower individuals, teams, and companies to unlock insights and discover new opportunities by providing unparalleled access to property intelligence.

Xilio Therapeutics

Series C in 2021
Xilio Therapeutics is a biotechnology company advancing next-generation cancer immunotherapies designed to improve patient outcomes by unleashing the power of the immune system selectively at the site of the tumor. The company’s tumor-selective immunotherapies are based on its proprietary technology, which maximizes the potency of proven immuno-oncology therapies and restricts their activity to the tumor to minimize peripheral side effects. The broad applicability of these therapies across cancer types means that all patients could benefit from these potentially curative medicines. These tumor-selective therapies are designed to overcome the significant toxicities associated with validated IO therapies, such as IL-2 and aCTLA4, which have historically limited the number of patients that can be treated and prevented patients from completing full courses of treatment Xilio Therapeutics proprietary technology enables the explosion of therapeutic activity specifically within the tumor while reducing toxicity throughout the body a nod to the company name, Xilio, derived from the Latin term, Ex Nihilo, meaning creation or big-bang. The company applying its technology to build a broad pipeline of engineered antibodies, cytokines and chemokines as potential new options for people living with cancer. Xilio Therapeutics was founded in 2016 and is headquartered in Waltham, Massachusetts, United States.

Nurix Therapeutics

Venture Round in 2020
Nurix develops small molecule inhibitors for the treatment of proliferative and degenerative diseases. The company’s product engine leverages a deep mechanistic understanding of the UPS to deliver effective small molecule drug candidates with the potential to make a dramatic difference for patients. Nurix drugs control ubiquitin E3 ligases, the key enzymes responsible for protein breakdown in human cells, as a unique therapeutic approach to treat a broad range of diseases. The company discovers drugs that harness the body's natural process to control protein levels. Their focus is on developing drugs to treat cancer including the novel, small molecule immuno-oncology agents. Nurix was founded in 2009 by internationally recognized experts in the ubiquitin-proteasome field and is funded by leading life science investors, Third Rock Ventures, and The Column Group. The company is headquartered in San Francisco, California.

EQRx

Series A in 2020
EQRx operates as a biotechnology company, focused on re-engineering the process from drug discovery to patient delivery with the goal of offering a market-based solution for the rising cost of medicines. By bringing together stakeholders from across the healthcare system and utilizing the latest advances in science and technology, the company seeks to discover, develop and deliver high-quality, patent-protected medicines more efficiently and cost-effectively than ever before. The company was founded in 2019 and is based in Cambridge, Massachusetts, United States.
Constellation Pharmaceuticals is the first biopharmaceutical company dedicated to the development of novel therapeutics in the emerging field of Epigenetics, a new field of science which is focused on selective regulators of epigenetic function, which are critical to controlling gene expression.

Physio-Control

Acquisition in 1994
Physio-Control, Inc., maker of renowned LIFEPAKÂ:registered: defibrillators, has been developing technologies and designing devices that are legendary among first response professionals, clinical care providers and citizens everywhere. Their defibrillators set the standard upon which an entire industry was built. From the beginning, their product development was customer-driven.

Lowes Cineplex

Acquisition in 2004
Lowes Cineplex

Centrient Pharmaceuticals

Acquisition in 2018
Centrient Pharmaceuticals develops, produces, and sells generic intermediates, active pharmaceutical ingredients (API), and drug products (DP). The products include penicillin G, beta-lactam intermediates, semi-synthetic penicillins, isoxazoles, cephalosporins, statins, and anti-fungals. Centrient Pharmaceuticals was formerly known as DSM Sinochem Pharmaceuticals Pte. Ltd. and changed its name to Centrient Pharmaceuticals in December 2018. The company was incorporated in 1869 and is based in Singapore.

Thoropass

Private Placement in 2020
Laika, Inc. develops information security and compliance-as-a-service software platform that enables business to manage compliance, and obtain security certifications. The company provides space for storing, sharing, and managing the components of business’s compliance program. The company reviews the client’s policies and procedures, and provides steps for compliance; organizes and controls system of record, and map it according to desired compliance requirements; and fosters collaboration on vendor security assessments. Laika, Inc. is based in New York, New York.

IQVIA

Public Offering in 2018
IQVIA is a global provider of advanced analytics, technology solutions and contract research services to the life sciences industry.

American Trailer Works

Acquisition in 2016
American Trailer Works, a company dedicated to providing the right product for people on the move. Their businesses each serve distinct trailer markets, ensuring American Trailer Works can build the trailer that’s right for you. We only sell trailers through qualified, independent retailers, so you always have a local partner to count on, no matter where you live, work or play.

Pharvaris

Series C in 2020
Pharvaris is a clinical-stage company focused on bringing an oral bradykinin B2 receptor antagonist to patients. By targeting this clinically proven therapeutic target with novel small molecules, we are progressing new alternatives to injected therapies for all sub-types of hereditary angioedema (HAE) and other B2 receptor-mediated indications. PHA121, Pharvaris’ lead drug candidate, is a novel and potent small-molecule bradykinin B2 receptor antagonist currently under Phase 1 clinical study. The co-founders of Pharvaris include an inventor of icatibant and the leadership from Jerini AG that developed icatibant for the treatment of HAE, now sold by Takeda under the brand name Firazyr®.

Arcutis Biotherapeutics

Private Placement in 2019
Arcutis Biotherapeutics is a privately held clinical-stage biopharmaceutical company focused on developing and commercializing treatments for unmet needs in immune-mediated dermatological diseases and conditions, or immuno-dermatology.

Affinivax

Private Placement in 2020
Affinivax, Inc., a biotechnology company, focuses on developing multiple antigen presenting system (MAPS) technology based vaccines that provide protection against various infectious diseases afflicting children and adults around the globe. Its MAPS enables the binding of protective polysaccharides and proteins in a single vaccine and induces a protective immune response. The company develops its vaccine programs to target various pathogens, such as streptococcus pneumoniae (pneumococcus), bacterial nosocomial infections, salmonella typhi, and staphylococcus aureus. Affinivax, Inc. was incorporated in 2014 and is based in Lexington, Massachusetts.

Atea Pharmaceuticals

Private Placement in 2020
Atea Pharmaceuticals is a biopharmaceutical company engaged in the discovery and development of next-generation therapeutics for severe human viral infections. It caters to the healthcare industry and engages in the discovery and development of antiviral therapeutics that enable patients to have treatment for infections caused by RNA and DNA viruses. Atea Pharmaceuticals was established in 2014 and is headquartered in Boston, Massachusetts.

Fedrigoni

Acquisition in 2018
Fedrigoni is an Italian producer of specialty papers and self-adhesive labels. Fedrigoni focuses its daily efforts on collaboration with clients – an approach instilled in all Group divisions and companies – so that a significant part of its production is made-to-measure for customers, thereby flanking the collection of more than 3,000 articles always new and always available in stock thanks to logistics integrating 8 branches in Italy, 6 in Europe and 3 in Asia. Still today a family-run business, Fedrigoni has overcome many recessions and two world wars, managing to consolidate and expand its operations in many production spheres and all over the world.

Savara

Post in 2020
Savara Inc. operates as an orphan lung disease company. Its lead product candidate includes Molgradex, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis; Phase IIa development stage for treating nontuberculous mycobacterial (NTM) lung infection; and in Phase IIa development stage for the treatment of NTM lung infection in people living with cystic fibrosis. The company is also developing AeroVanc, an inhaled vancomycin that is in Phase III development stage for the treatment of methicillin-resistant Staphylococcus aureus lung infection in individuals living with cystic fibrosis. Savara Inc. is headquartered in Austin, Texas.

Evident.io

Series B in 2016
As of March 26, 2018, Evident.io, Inc. was acquired by Palo Alto Networks, Inc. Evident.io, Inc. develops and offers a software platform for enterprise security management. The company offers cloud security services, including resource visibility, vulnerability assessment, and notifications and alerting; risk and compliance services; and Amazon Web services. Evident.io, Inc. was incorporated in 2013 and is based in Pleasanton, California.

US LEC

Post in 2000
US LEC is a rapidly growing CLEC that provides switched local, long distance and enhanced telecommunications services primarily to medium and large-sized organizations located in selected markets in the southeastern United States. The Company was founded in June 1996 after passage of the Telecom Act, which enhanced the competitive environment for local exchange services. The Company initiated service in Charlotte, North Carolina in March 1997, becoming one of the first CLECs in North Carolina to provide switched local exchange services, and subsequently initiated service in Raleigh and Greensboro, North Carolina and in Atlanta, Georgia. As of February 28, 1998, the Company had 62,545 Equivalent Access Lines in service. US LEC plans to enter 15 new markets in Tennessee, Florida, South Carolina, Virginia and North Carolina by the end of 1999.
A complete offer of business integration, application and infrastructure outsourcing, innovative solutions and strategic consultancy. The parent company Engineering Ingegneria Informatica has been listed on the Milan stock market since December 2000 and the ordinary shares are part of the FTSE Italia STAR index, which includes stock with the highest industrial and equity requisites. Designing and creating innovative architecture that guide and support all the organizations' business and service models in all markets. Promoting innovation in organizations, processes and services with the passion and enthusiasm of an Italian company.

Rapid Micro Biosystems

Private Placement in 2020
Rapid Micro Biosystems provides products for the detection of microbial contamination in the manufacture of pharmaceutical, biotechnology, and personal care products. It offers the Growth Direct System, a non-destructive method for microbial enumeration. The company was formerly known as Genomic Profiling Systems and changed its name to Rapid Micro Biosystems in 2007. Rapid Micro Biosystems was founded in 2006 and is based in Bedford, Massachusetts.

Hugel Control

Post in 2017
HUGEL, Inc. strives to be a global company that continuously creates innovative products, promotes universal health, and improves the quality of life through state-of-the-art technology and creativity.

Qinhuai Data

Acquisition in 2019
Qinhuai Data was established in 2004. The company focuses on industrial ecological planning, investment, construction, testing and operation of cloud computing infrastructure. The controlling shareholder, NetScience Technology Co., Ltd., is the leading joint-stock listed company in the field of Internet computing in China. It mainly provides customers with global content distribution and acceleration, server hosting and leasing, and network optimization for bandwidth resources. supplier. In August 2015, we jointly established Beijing Qinhuai Data Co., Ltd. with NetScience Technology, invested and operated its own IDC Internet data center in Beijing, Shanghai, Guangzhou and Shenzhen, and leased and operated more than 170 operators' operating rooms worldwide in the data center. Provide resources and services to partners in the entire ecological industry chain for resource development, project operation and maintenance of construction operations, IT server hardware custom operation and maintenance, broadband access value-added services, and long-distance transmission link solutions.

Basis

Initial Coin Offering in 2017
Basis protocol is designed to expand and contract supply similarly to the way central banks buy and sell fiscal debt to stabilize purchasing power. For this reason, we refer to Basis as having an algorithmic central bank.

Autodis Group

Acquisition in 2015
Autodis Group is a major European player in the distribution of spare parts and independent multi-brand repairs to Automotive and Heavyweight, which accompanies companies to become leaders in their markets.

Bapcor

Private Equity Round in 2024
Bapcor is Australasia's leading provider of automotive aftermarket parts, accessories, automotive equipment and services. Bapcor’s core business segment is the automotive aftermarket, covering Trade, Retail & Service, and Specialist Wholesale businesses.Their Trade businesses include Burson Auto Parts and BNT, and house amongst the widest range of car parts in the world for over 400 makes and models.Retail & Service businesses include Autobarn, Australia's premium retail offering, Autopro, Sprint Auto Parts, Opposite Lock and Car Parts, and Service businesses Midas, ABS and The Shock Shop.

Savara

Post in 2024
Savara Inc. operates as an orphan lung disease company. Its lead product candidate includes Molgradex, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis; Phase IIa development stage for treating nontuberculous mycobacterial (NTM) lung infection; and in Phase IIa development stage for the treatment of NTM lung infection in people living with cystic fibrosis. The company is also developing AeroVanc, an inhaled vancomycin that is in Phase III development stage for the treatment of methicillin-resistant Staphylococcus aureus lung infection in individuals living with cystic fibrosis. Savara Inc. is headquartered in Austin, Texas.

Pomerium

Series A in 2024
Pomerium authenticates, authorize, monitor, and secure user access to any application without a VPN. Pomerium provides a standardized interface to add access control whether an application itself has authorization or authentication baked-in. Let developers focus on their apps, not reinventing access control.

Kestra Medical Technologies

Private Equity Round in 2024
Kestra Medical Technologies, Inc. develops and manufactures wearable medical devices for monitoring and managing acute medical conditions. The company provides wearable solutions to collect, communicate, and store patient performance data, with real-time and retrospective analysis. Additionally, it offers wearable cardioverter defibrillators to prevent sudden cardiac death and assist cardiac recovery in at-risk patients. Kestra Medical Technologies, Inc. was founded in 2014 and is headquartered in Kirkland, Washington.

Bio Products Laboratory Holding

Acquisition in 2013
Bio Products Laboratory Holding manufactures and supplies blood plasma products. It transforms blood plasma into treatments for immune deficiencies, neurological diseases, and hemophilia.

Annexon Biosciences

Private Placement in 2018
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune and neurodegenerative diseases. It focuses on the treatment of body, brain, and eye disorders. The company’s C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated neurodegeneration. Its product candidates include ANX005, which has completed Phase 1b clinical trials to treat patients with guillain- barré syndrome; and ANX007, which has completed Phase 1b clinical trials to treat patients with glaucoma. The company’s candidates also comprise ANX005 that has completed preclinical trials to treat patients with warm autoimmune hemolytic anemia, Huntington's disease, and amyotrophic lateral sclerosis; ANX007, which has completed preclinical trials for the treatment of geographic atrophy; and ANX009 that has completed preclinical trials for the treatment of systemic autoimmune diseases. The company was founded in 2011 and is headquartered in South San Francisco, California.

Fintyre

Acquisition in 2017
The Fintyre group is the distributor of replacement tyres in Italy, and each year sells more that 4 million tyres with the aim of expanding and consolidating its current market position. The Fintyre group operates right across the country and is among the strongest presences in the sector. Fintyre is the main contact for professional stockists for all vehicles looking for a reliable and knowledgeable partner with a strong contractual capacity.

Healthdrive Corporation

Acquisition in 2019
HealthDrive was founded in 1989 by medical professionals who saw the need for a higher level of on-site medical and dental services in long-term care facilities. Their founders began assembling specialty doctors, skilled providers and practitioners who were rated to be the best in their field. Since then, HealthDrive has grown to employ 120 medical and dental providers in over 1,000 facilities, serving more than 135,000 senior living residents around the nation. They understand the critical importance of good health and how it leads to a better quality of life. Their highly skilled on-site medical service providers not only deliver proactive healthcare to seniors in long-term care facilities, but deliver those services with the utmost care and empathy. HealthDrive provides long-term care residents with dental, optometry, podiatry and audiology services where they reside, bringing services to senior living facilities who partner with us. Learn more about what makes us a leading provider:

Italmatch Chemicals

Acquisition in 2018
Italmatch Chemicals majors in the production of phosphorus derivatives, giving it a unique strength and leading position in the international market. Although a relatively small company, compared to its main competitors, Italmatch Chemicals has earned the respect and trust, over a period of years, of such Multinationals leaders in their sectors, with particular regard to lubricant oil additives (L.O.A.), plastic & polymers flame retardant additives (F.R.) and other various industrial applications. The wide sector already encompassed by Italmatch Chemicals is destined to expand even larger thanks to its historical ambition of growth. The ability to combine the reliability of tradition with the opportunities offered by modern technology, implemented by an expert and dynamic management, results in Italmatch Chemical’s unparalleled creativity, competence and Customers satisfaction. By focusing on today’s dynamic world of specialty chemicals and its expanding horizons, Italmatch Chemicals offers advanced and effective solutions based largely, but not exclusively, on phosphorus derivatives. Careful environmental concern stands to witness the Company long term commitment to the market, as the technologically advanced systems adopted in its Spoleto plant stand to prove, with particular respect to the optimisation of environmental impact and increased safety. For these reasons the Company has recently obtained the ISO 14001:2004 Environmental Certification, and is operating according to both an Environmental Management System as well as a Safety Management System, both subject to periodical revisions and audits.
Syros Pharmaceuticals is a life sciences company that is focused on treating disease by mapping gene regulatory circuits and modulating the factors that regulate gene expression. Syros has pioneered world-leading gene control research and drug discovery capabilities with a proven ability to integrate disease biology and genomic data--a proficiency that is not well represented in pharmaceutical R&D. Central to the Syros approach is a proprietary platform of carefully integrated assay technologies, bioinformatics, and biologic insights developed by members of Syros' senior leadership. While this scientific approach has applications in many therapeutic areas, Syros has demonstrated success initially in oncology, where it may help address numerous unmet medical needs.

TravelCLICK

Venture Round in 2001
TravelClick provides cloud-based software solutions for hoteliers worldwide. It offers reservation solutions such as iHotelierm that is a central reservation system, iHotelier Web 3.0 that is a game-changing web booking engine, iHotelier Mobile that is a mobile booking engine, iHotelier Global Distribution Systems (GDS) that promotes hotel’s availability in third party channels, Channel Management that provides hotel channel management solutions, iHotelier VoicePro, a private label voice reservations solution, iHotelier Demand that offers access to distribution channels and partnerships, and iHotelier PMS, a property management system solution. TravelClick provides business intelligence solutions that include Rate360 that is a rate comparison tool, Agency360 that gives access to the database of agency bookings, Demand360 that offers access to information and in-depth reports and Enterprise Solutions that is a platform that provides market research and analytical tools. It offers media solutions such as Travel Agent Media that is a solution that drives high value bookings, Display Marketing that is a tool for researching hotels and display remarketing, and Pay-Per-Click Advertising that helps to drive traffic and bookings to hotel’s website. TravelClick provides web solutions in the areas of custom websites, search engine optimization, and social media optimization, guest management, a customer relationship management database and e-mail marketing solution, and training and support services. Global Marketing Services that began operation in 1987 later became TravelClick. TravelClick has its headquarters in New York City. It has additional offices in Barcelona in Spain, Chicago in Illinois in Dubai in the United Arab Emirates, Atlanta in Georgia, Melbourne in Australia, Singapore, Shanghai in China; Hong Kong, New York City, Philadelphia in Pennsylvania, Orlando in Florida, and Tokyo in Japan.

Big Tex

Acquisition in 2015
Founded in 1982 and based in Mt. Pleasant, TX, Big Tex is the nation’s leading manufacturer and retailer of professional-grade open utility trailers and truck beds. The Company services its network of hundreds of dealers through its footprint of eight facilities through the US. The Company’s Trailer World division is the largest retailer of trailers in the US through a network of over 40 Company-owned retailers. The Company’s Tex Trail division is a leading wholesaler of trailer parts through 12 nationwide distribution facilities.

Annexon Biosciences

Private Placement in 2020
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune and neurodegenerative diseases. It focuses on the treatment of body, brain, and eye disorders. The company’s C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated neurodegeneration. Its product candidates include ANX005, which has completed Phase 1b clinical trials to treat patients with guillain- barré syndrome; and ANX007, which has completed Phase 1b clinical trials to treat patients with glaucoma. The company’s candidates also comprise ANX005 that has completed preclinical trials to treat patients with warm autoimmune hemolytic anemia, Huntington's disease, and amyotrophic lateral sclerosis; ANX007, which has completed preclinical trials for the treatment of geographic atrophy; and ANX009 that has completed preclinical trials for the treatment of systemic autoimmune diseases. The company was founded in 2011 and is headquartered in South San Francisco, California.

Kymera Therapeutics

Private Placement in 2020
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body’s own natural protein degradation system. It engages in developing IRAK4 program for the treatment of immunology-inflammation diseases, including hidradenitis suppurativa, atopic dermatitis, and rheumatoid arthritis; IRAKIMiD program to treat MYD88-mutated diffuse large B cell lymphoma; and STAT3 program for the treatment of hematologic malignancies and solid tumors, as well as autoimmune diseases. The company was founded in 2015 and is headquartered in Watertown, Massachusetts.

Attivo Networks

Series C in 2019
Attivo Networks provides required visibility and actionable, substantiated alerts to detect, isolate, and defend against cyber attacks. Attivo Networks, the leader in deception technology, provides accurate in-network threat detection, analysis, and accelerated response to advanced, credential, insider, and ransomware attacks. The Attivo Deception and Response Platform provide continuous visibility and efficient threat management for user networks, data centers, cloud, branch, IoT, ICS-SCADA, and POS environments. Camouflage dynamic deception sets high-interaction traps to misdirect and lure attackers into revealing themselves. The solution’s advanced attack analysis and lateral movement tracking automate investigation, deliver evidence-based alerts, and in-depth forensic reports. Incident response is simplified with ThreatOps™ playbooks and 3rd party integrations for automated attack blocking, quarantine, and threat hunting.

ProfitLogic

Series C in 2003
ProfitLogic engages in the development and marketing of retail profit optimization software solutions. It offers retail profit optimization, price optimization, and inventory planning software solutions for all retail verticals, which include assortment and allocation, pricing, in-season inventory management, promotions and marketing, and performance assessment and management solutions. The company provides applications to help retailers make profitable allocation, planning, and pricing decisions; and a marketer of profit optimizations systems. ProfitLogic, Inc. was formerly known as Technology Strategy, Inc. (TSI). The company was founded in 1983 and is based in Cambridge, Massachusetts.

Socar

Series A in 2014
Socar is a Korean eco-friendly car sharing community that allows travelers to share cars with others who are traveling the same route. Socar has raised an $18 million round of funding in 2015 which was one of the highest funding deals for a South Korean startup to date. Most notably, it was led by a US investor: Bain Capital, a private investment firm with $80 billion in assets under management. Socar was founded in March 2012, and it has a website and smartphone apps that let users book cars for their own use. Service has over 1,700,000 registered users, 50,000 of whom use the service each month. Around 80,000 transactions per month — that’s more than one car booking each 30 seconds.

Areteia Therapeutics

Series A in 2022
Areteia Therapeutics is a biotechnology company committed to putting asthma patients in better control of their disease. The company was spun out of Pennsylvania-based Knopp, which published results from its phase 2 clinical trial last year that showed its oral drug candidate could reduce the count of blood eosinophil, which is an indication of improving lung function and is found in several asthma-related treatments.

Nimbus Apollo

Venture Round in 2022
Nimbus Discovery is now Nimbus Therapeutics to reflect our transition into a clinical stage company. Nimbus Therapeutics is a biotechnology company headquartered in Cambridge, Mass., that is pioneering a new computational technology-driven paradigm to rapidly advance a diverse pipeline of novel small molecule product candidates into clinical development. We are designing highly selective and potent medicines to disrupt known drivers of serious diseases, including metabolic disease, cancer and immune-inflammatory disorders.

LivHome

Acquisition in 2018
LivHOME offers a variety of professional home care services which include personal care, respite care, companion care, dementia care, and more. Their caregivers are available on an hourly or 24-hour basis with flexible hours and no long-term contracts. LivHOME offers the most comprehensive home care services for the elderly, providing a combination of caregiving, care management, and care technology that have shown to improve outcomes at home while contributing to your loved one’s well-being.

FTE Automotive

Acquisition in 2013
The FTE automotive Group is your competent partner in the sector of development and production of drive train and brake system applications for the automotive industry. The company is located in all important continents and one of the leading OE-suppliers for passenger cars and commercial vehicles worldwide.

Interpath Communications

Private Equity Round in 2000
Interpath is a full-service ASP, offering delivery and end-to-end support of today's critical business applications. Our expertise in consulting, implementation, hosting and application management allows us to provide robust, turnkey eBusiness solutions to fast-growing companies. Interpath has partnered with world-class hardware and software vendors such as BroadVision, IBM, SAP, Sun Microsystems and Vignette, to provide businesses with a portfolio of best-in-class applications - everything from ERP apps to robust eCommerce solutions.

Axis Bank

Post in 2017
Axis Private Equity Advisors, formerly Axis Private Equity, provides advisory services to companies looking to raise capital from institutional investors. After raising the $150 million Infrastructure Fund in 2008, the firm decided to sell its fund management business in 2010. Investors balked at the idea, however, and Axis was forced to wind down the fund instead. Today, Axis remains involved in private equity, but solely in an advisory role.Axis Capital’s Private Equity Advisory team provides end-to-end advisory services to companies looking to raise equity/quasi-equity from financial investors.

netLibrary

Series C in 1999
NetLibrary, provides access to electronic books (eBooks), including reference books.

Pharvaris

Private Placement in 2019
Pharvaris is a clinical-stage company focused on bringing an oral bradykinin B2 receptor antagonist to patients. By targeting this clinically proven therapeutic target with novel small molecules, we are progressing new alternatives to injected therapies for all sub-types of hereditary angioedema (HAE) and other B2 receptor-mediated indications. PHA121, Pharvaris’ lead drug candidate, is a novel and potent small-molecule bradykinin B2 receptor antagonist currently under Phase 1 clinical study. The co-founders of Pharvaris include an inventor of icatibant and the leadership from Jerini AG that developed icatibant for the treatment of HAE, now sold by Takeda under the brand name Firazyr®.